American scientists reported that the oral drug daraxonrasib nearly doubles survival time in patients with advanced pancreatic cancer, marking one of the most promising developments in the disease's treatment.
Search
Congressional trades, bills, prediction markets, hearings, and intelligence signals. Signal search supports: AND OR "exact phrase" -exclude